BrainScope makes a portable medical device that can quickly assess a range of TBI. The company’s tech recently received clearance from the FDA for use as a “multi-modal, multi-parameter assessment,” to determine the likelihood that someone has suffered a “concussion” or “mild traumatic brain injury,” and evaluate how severe the injury may be.
BrainScope One uses non-invasive EEG-based technology to assess mildly presenting head injuries in patients. The tech’s new FDA classification adds to its list of existing clearances, including for the ability to identify patients who may have a brain bleed. BrainScope One is currently being used by the U.S. military, as well as in urgent care and occupational health clinics, concussion clinics, hospital emergency rooms, university sports and health centers and in pharmaceutical clinical trials.